HIGH

Civco Medical Instruments Recalls 6 eTRAX Needle System Starter Kits for Aurora Trackers (2026)

Civco Medical Instruments recalled 6 units of the eTRAX Needle System Starter Kit 14G for Aurora Trackers distributed to medical facilities in Ohio, Pennsylvania and Washington. The recall stems from an inspection and programming error in the needle sensor. Healthcare providers and patients should stop using the device immediately and follow the manufacturer’s recall instructions.

Quick Facts at a Glance

Recall Date
March 2, 2026
Hazard Level
HIGH
Brand
Civco Medical Instruments Co.
Category
Health & Personal Care
Sold At
Unknown
Geographic Scope
3 states
At-Risk Groups
GENERAL

Hazard Information

There was an error in inspection and programming of the eTRAX needle sensor for Aurora trackers. The result is a potential for the needle tip position to be incorrectly identified on the user interface.

What You Should Do

Patients and healthcare providers should stop using this device immediately. Follow the recall instructions provided by the manufacturer. Contact Civco Medical Instruments Co. Inc. or your healthcare provider for instructions

Get instant alerts for Health & Personal Care recalls

Be the first to know. Free instant alerts to your inbox.

No spamUnsubscribe anytime

Product Details

Model numbers: Part Number 667-150. UDI-DI 00841436111041. Lot Number A228673. Sold to healthcare facilities in OH, PA and WA. Quantity recalled: 6 units. Country of origin: China. Price: Unknown.

The Hazard

An error in inspection and programming of the eTRAX needle sensor could cause the needle tip position to be incorrectly identified on the user interface.

Reported Incidents

No injuries or incidents have been reported.

What to Do

1. Stop using the product. 2. Follow the recall instructions provided by the manufacturer. 3. Contact Civco Medical Instruments Co. Inc. or your healthcare provider for instructions.

Contact Information

Manufacturer contact details are not provided in the recall notice. Consumers should consult the FDA recall page for official guidance.

Key Facts

  • 6 units recalled
  • Part Number 667-150
  • UDI-DI 00841436111041
  • Lot Number A228673
  • Distributed to OH, PA, WA (USA) and China
  • Hazard: incorrect needle tip identification on UI
View Original Recall on FDA - Medical Devices

Browse More Recalls

More from FDA_DEVICEHealth & Personal CareMedical Devices

Safety Guide

Not sure what to do next? Our guide walks you through the process step by step.

Read: What to Do When You Find a Recalled Product

Get Alerts for Health & Personal Care Recalls

Get instant alerts for recalls that affect you. Free forever.

Safety Assessment

Risk LevelHIGH
Severity Score
8/ 10
Affected Groups
GENERAL
Injury Types
OTHER

Product Classification

Product TypeNeedle System Starter Kit 14G
Sold At
Unknown

Product Details

Model Numbers
667-150
00841436111041
A228673
Affected States
OH, PA, WA
Report Date
April 8, 2026
Recall Status
ACTIVE

Related Recalls

Health & Personal Care
CRITICAL

Massive Eye Drop Recall Hits CVS, Walgreens, Kroger — 8 Products Never Tested for Sterility (2026)

Millions of eye drop bottles sold at CVS, Walgreens, Kroger, and other major pharmacies may not be sterile. K.C. Pharmaceuticals of Pomona, California never verified that eight of its over-the-counter eye drop products met sterility standards, the FDA warned. A nearly identical manufacturing failure in 2023 left patients blind, cost others their eyes, and killed at least three people. Consumers should stop using the products and return them for a full refund.

CVS Health
Nonsterile eye
Read more
Health & Personal Care
HIGH

Biocon Pharma Prazosin Hydrochloride 1mg 100-Count Capsules Recalled for Nitrosamine Impurity (2026)

Biocon Pharma Inc. recalled 88,008 bottles of Prazosin Hydrochloride capsules, 1 mg, 100-count bottles, nationwide in the United States. A cGMP deviation detected N-nitroso-prazosin impurity C above acceptable limits. Consumers and healthcare providers should stop using this product immediately and contact Appco Pharma LLC or a healthcare provider for guidance.

Biocon Pharma
cGMP deviation:
Read more
Health & Personal Care
HIGH

Biocon Pharma Prazosin Hydrochloride 5mg Recall 28,157 Bottles Over Nitrosamine Impurity (2026)

Biocon Pharma Inc. recalled 28,157 bottles of PRAZOSIN HYDROCHLORIDE capsules, distributed nationwide in the USA. The recall cites cGMP deviation due to detection of N-nitroso-prazosin impurity C above acceptable limits. Stop using the product immediately and contact Appco Pharma LLC or your healthcare provider for guidance.

Prazosin Hydrochloride
cGMP deviation:
Read more
Health & Personal Care
HIGH

Biocon Prazosin Hydrochloride 2 mg Capsules Recalled for Nitrosamine Impurity (58,896 bottles, 2026)

Biocon Pharma Inc. recalled 58,896 bottles of Prazosin Hydrochloride Capsules, USP, 2 mg, 100-count bottle. The product was distributed nationwide in the USA and manufactured by Appco Pharma LLC. A cGMP deviation detected N-nitroso-prazosin impurity C above acceptable limits. Consumers and healthcare providers should stop using this product immediately and contact Appco Pharma LLC or their health‑

Prazosin Hydrochloride
cGMP deviation:
Read more
Health & Personal Care
HIGH

Amneal TRAMADOL HYDROCHLORIDE 50 mg Recall 29,542 Bottles Over Impurity (2026)

Amneal Pharmaceuticals is recalling 29,542 bottles of TRAMADOL HYDROCHLORIDE tablets distributed nationwide in the United States. The recall cites a failed impurity specification for N-nitroso-desmethyl-tramadol (NDSRI) at the 24‑month stability interval. Consumers and healthcare providers should stop using the product immediately and contact Amneal for guidance.

TRAMADOL HYDROCHLORIDE
Failed Impurities/Degradation
Read more
Health & Personal Care
MEDIUM

AvKARE Recalls Rosuvastatin Tablets Due to Dissolution Issues

AvKARE recalled 7,991 cartons of Rosuvastatin Tablets on December 31, 2025. The recall stems from the product being out of specification for dissolution. Consumers should stop using the medication immediately and consult healthcare providers for guidance.

MAGNESIUM SULFATE
Product mix
Read more
Health & Personal Care
HIGH

Teva Octreotide Acetate Injectable Suspension Recall 21,930 Cartons Over Sterility Risk (2026)

Teva Pharmaceuticals recalled 21,930 cartons of Octreotide Acetate for Injectable Suspension distributed nationwide in the United States. The recall stems from lack of assurance of sterility identified during an FDA inspection at the contract manufacturer. Healthcare providers and patients should stop using this product immediately and contact Teva or a physician for guidance.

OCTREOTIDE ACETATE
Lack of
Read more